Login
Who We Are Lisa Hightow-Weidman, Ph.D
Lisa Hightow-Weidman, Ph.D
Distinguished & Endowed McKenzie Professor and the Associate Dean for Research in the College of Nursing, Florida State University (FSU)
Profile
Nominee Election Year to ASEMFL: 2024
Nominee Committee Service (List Committee and Years Served): ASEMFL membership committee (2025-current); ASEMFL annual meeting planning committee (2025-current)
Nominator Name: Greg Boebinger, FSU
Description of technical expertise, past leadership experience, and goals for ASEMFL position: (300 Word limit) Lisa Hightow-Weidman is the founding Director of FSU’s Institute on Digital Health and Innovation (IDHI) and has over 20 years of experience providing patients with HIV prevention and care services as an infectious disease physician. She is the creator of a digital health platform that has been used in numerous health promotion intervention trials across the US and in 8 countries globally and is widely recognized as a leading expert globally in adolescent HIV prevention and care research.
Lisa received her MD in 1998 from the University of Virginia School of Medicine and completed both her MPH in Epidemiology (2003) and an Infectious Diseases Fellowship (2004) at UNC-Chapel Hill. Her publications have been cited more than 10,000 times and she has an h-index at 56 (per Google Scholar). Lisa has held major leadership roles in both academic and scientific organizations. Highlights of that service include but are not limited to: Associate Dean for Research, College of Nursing, Florida State University (2023-present); Director, Institute on Digital Health and Innovation, Florida State University (2022-present); FSU Health Clinical Research Steering Committee (2024-present); Chair, New Technologies for Health: AI/Machine Learning/mHealth Scientific Committee, HIV Prevention Trials Network (HPTN) (2025-present); Executive Committee, Adolescent Medicine Trials Network for HIV Interventions (Member 2016-2019, Chair 2020-2022); Chair, NIH Special Emphasis Panel, Mobile Health: Technology and Outcomes in Low- and Middle-Income Countries (2021); Consulting Editor, Stigma and Health (2024-present); and Associate Editor, Sexually Transmitted Diseases (2014-2018).
Beyond her scientific and administrative skills is an equally important aspect to consider Lisa Hightow-Weidman is a collaborative colleague and a delight to work with. ASEMFL would be well served to elect her to become a member of the ASEMFL Board of Directors.
Nominee Committee Service (List Committee and Years Served): ASEMFL membership committee (2025-current); ASEMFL annual meeting planning committee (2025-current)
Nominator Name: Greg Boebinger, FSU
Description of technical expertise, past leadership experience, and goals for ASEMFL position: (300 Word limit) Lisa Hightow-Weidman is the founding Director of FSU’s Institute on Digital Health and Innovation (IDHI) and has over 20 years of experience providing patients with HIV prevention and care services as an infectious disease physician. She is the creator of a digital health platform that has been used in numerous health promotion intervention trials across the US and in 8 countries globally and is widely recognized as a leading expert globally in adolescent HIV prevention and care research.
Lisa received her MD in 1998 from the University of Virginia School of Medicine and completed both her MPH in Epidemiology (2003) and an Infectious Diseases Fellowship (2004) at UNC-Chapel Hill. Her publications have been cited more than 10,000 times and she has an h-index at 56 (per Google Scholar). Lisa has held major leadership roles in both academic and scientific organizations. Highlights of that service include but are not limited to: Associate Dean for Research, College of Nursing, Florida State University (2023-present); Director, Institute on Digital Health and Innovation, Florida State University (2022-present); FSU Health Clinical Research Steering Committee (2024-present); Chair, New Technologies for Health: AI/Machine Learning/mHealth Scientific Committee, HIV Prevention Trials Network (HPTN) (2025-present); Executive Committee, Adolescent Medicine Trials Network for HIV Interventions (Member 2016-2019, Chair 2020-2022); Chair, NIH Special Emphasis Panel, Mobile Health: Technology and Outcomes in Low- and Middle-Income Countries (2021); Consulting Editor, Stigma and Health (2024-present); and Associate Editor, Sexually Transmitted Diseases (2014-2018).
Beyond her scientific and administrative skills is an equally important aspect to consider Lisa Hightow-Weidman is a collaborative colleague and a delight to work with. ASEMFL would be well served to elect her to become a member of the ASEMFL Board of Directors.